Waltham, MA – October 21, 2008: CRF Inc. (CRF), a leading global provider of electronic Patient Reported Outcomes (ePRO) and wireless data collection solutions for the Life Science Industry, today announced that its Board of Directors has appointed Rachael King to serve as the company’s Chief Executive Officer, effective immediately.

Formerly CRF’s Vice President of European and Asian Operations, Ms. King has been instrumental in developing and growing new markets for the company.  She has also been the chairperson of the company’s influential Clinical Advisory Board.  With Ms. King’s extensive background in pharmaceutical research and information technology, she is well positioned to lead the company to further growth in the industry.

Board Chairman, Alan Howarth, said, “We are delighted to welcome Rachael King as CEO.  She is a proven executive with an exceptional blend of strategic, business, and leadership skills.  We are confident that she is the ideal person to further strengthen CRF’s position as a key player in the clinical trials technology field.”

Commenting on her appointment, Ms. King said, “I am honored and excited to assume this new position.  I look forward to continuing CRF’s tradition of technological innovations and complete study management solutions, and helping the company achieve its next phase of growth.”

About CRF Inc.

CRF Inc. (“CRF”) is a leading global provider of electronic Patient Reported Outcomes (“ePRO”) and wireless data collection solutions for the Life Science Industry.  Through innovative technology and a thorough understanding of drug development and mobile computing, CRF is driving the change to safer and more efficient paper-free clinical trials.  CRF's technology has been used by more than 180,000 patients across 59 countries in 60 languages for 45 indications.  The company has demonstrated one of the industry's highest patient compliance rates – an average 90% compliance through Phase I, II, III and IV clinical trials.

CRF's award-winning product, the TrialMax^® suite, is a flexible and configurable ePRO technology that provides real-time patient monitoring, outstanding data accuracy and increased safety through compliance.  The TrialMax application’s unique features enable clinical trial sponsors to rapidly collect valuable data and conduct complex clinical trials with greater flexibility than other ePRO solutions.  CRF's experience, combined with its dedication to achieving the highest quality and most responsive customer service, has made the company one of the life science industry's most trusted partners.

For more information, please visit www.crfhealth.com.

TrialMax®, TrialCollector®, TrialIntegrator®, TrialManager® and TrialStudio® are registered trademarks of CRF Inc.  All rights reserved.  TrialLibrary™ and other CRF product references are either a trademark or service mark of CRF Inc.  All rights reserved.  All other trademarks and/or service marks are the property of their respective owners.

Press Contacts:

UK:

Nicola Craft/ Joanna Quayle/ John Brown

Buffalo Communications

Tel: +44 (0) 20 7 292 8680

crf@buffalo.co.uk

US:

Lisa Felice

Tel: +1 781 835 6539

lisa.felice@crfhealth.com